Target Name: LEPROTL1
NCBI ID: G23484
Review Report on LEPROTL1 Target / Biomarker Content of Review Report on LEPROTL1 Target / Biomarker
LEPROTL1
Other Name(s): my047 | Leptin receptor overlapping transcript-like 1 | Vps55 | LEPROTL1 variant 2 | leptin receptor overlapping transcript like 1 | LERL1_HUMAN | endospanin-2 | Leptin receptor overlapping transcript like 1, transcript variant 2 | HSPC112 | Endospanin-2 | Leptin receptor overlapping transcript-like 1 (isoform 2)

LEPROTL1: A Potential Drug Target for Age-Related Lens Loss

LEPROTL1 (my047) is a protein that is expressed in the lens of the eye. It is a member of the LEPROTL family which includes four structurally similar proteins, LEPROTL2, LEPROTL3, LEPROTL4 and LEPROTL5. LEPROTL1 is unique as it is the only protein that is expressed in the lens and not in the retina. The lens plays a crucial role in vision as it is the window through which light enters the eye and focuses on the retina. Therefore, any protein that is expressed in the lens and not in the retina is of great interest as it may be a drug target or a biomarker.

LEPROTL1 is a 16kDa protein that is expressed in the lens of the eye. It is a member of the LEPROTL family which includes four structurally similar proteins, LEPROTL2, LEPROTL3, LEPROTL4 and LEPROTL5. These proteins are involved in the development, maintenance and regression of the lens structure and function. LEPROTL1 is unique as it is the only protein that is expressed in the lens and not in the retina.

The lens plays a crucial role in vision as it is the window through which light enters the eye and focuses on the retina. Therefore, any protein that is expressed in the lens and not in the retina is of great interest as it may be a drug target or a biomarker. The lens is responsible for focusing light onto the retina, which is the site of photoreceptor cells that produce the visual information we see. The lens also plays an important role in correcting refractive errors and ensuring that light enters the eye at the correct angle.

LEPROTL1 is a protein that is expressed in the lens of the eye and is involved in the regulation of lens structure and function. It is a key regulator of lens growth and development and plays a role in the regulation of lens response to light. LEPROTL1 is a promising drug target as it is involved in the development and maintenance of the lens structure and function, which may be related to the development of age-related lens loss and other lens-related disorders.

LEPROTL1 is a 16kDa protein that is expressed in the lens of the eye and is a member of the LEPROTL family. It is unique as it is the only protein that is expressed in the lens and not in the retina. LEPROTL1 is involved in the regulation of lens structure and function and is a key regulator of lens growth and development. As a result, LEPROTL1 is of great interest as a drug target or a biomarker for the development of age-related lens loss and other lens-related disorders.

In conclusion, LEPROTL1 is a protein that is expressed in the lens of the eye and is involved in the regulation of lens structure and function. It is a key regulator of lens growth and development and plays a role in the regulation of lens response to light . As a result, LEPROTL1 is of great interest as a drug target or a biomarker for the development of age-related lens loss and other lens-related disorders. Further studies are needed to fully understand the role of LEPROTL1 in the regulation of lens structure. and function.

Protein Name: Leptin Receptor Overlapping Transcript Like 1

Functions: Negatively regulates growth hormone (GH) receptor cell surface expression in liver. May play a role in liver resistance to GH during periods of reduced nutrient availability

The "LEPROTL1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LEPROTL1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LERFS | LETM1 | LETM2 | LETMD1 | LETR1 | Leukotriene B4 receptor (LTB4-R) | Leukotriene CysLT receptor | LEUTX | LEXM | LFNG | LGALS1 | LGALS12 | LGALS13 | LGALS14 | LGALS16 | LGALS17A | LGALS2 | LGALS3 | LGALS3BP | LGALS4 | LGALS7 | LGALS7B | LGALS8 | LGALS8-AS1 | LGALS9 | LGALS9B | LGALS9C | LGALSL | LGI1 | LGI2 | LGI3 | LGI4 | LGMN | LGMNP1 | LGR4 | LGR5 | LGR6 | LGSN | LHB | LHCGR | LHFPL1 | LHFPL2 | LHFPL3 | LHFPL3-AS1 | LHFPL3-AS2 | LHFPL4 | LHFPL5 | LHFPL6 | LHFPL7 | LHPP | LHX1 | LHX2 | LHX3 | LHX4 | LHX4-AS1 | LHX5 | LHX6 | LHX8 | LHX9 | LIAS | LIF | LIFR | LIFR-AS1 | LIG1 | LIG3 | LIG4 | LILRA1 | LILRA2 | LILRA3 | LILRA4 | LILRA5 | LILRA6 | LILRB1 | LILRB2 | LILRB3 | LILRB4 | LILRB5 | LILRP1 | LILRP2 | LIM domain kinase (LIMK) | LIM2 | LIMA1 | LIMASI | LIMCH1 | LIMD1 | LIMD1-AS1 | LIMD2 | LIME1 | LIMK1 | LIMK2 | LIMS1 | LIMS2 | LIMS3 | LIMS3-LOC440895 | LIMS4 | LIN28A | LIN28B | LIN28B-AS1 | LIN37 | LIN52